MedPath

Effects of high frequency repetitive transcranial magnetic stimulation and sertraline on depressive symptoms in patients after ischemic stroke

Phase 3
Completed
Conditions
Post stroke depression
Repetitive transcranial magnetic stimulation
Antidepressant
Registration Number
TCTR20180112001
Lead Sponsor
Faculty of Medicine Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria

-Ischemic stroke patients
-Age 18 years or more
-Have depressive symptoms (diagnosed with DSM-IV-TR)
-No antidepressant taken

Exclusion Criteria

-Have other neurological diseases
-Had depression prior to stroke
-Had seizure, epilepsy or history of head trauma
-Have pacemaker or metallic implant inside the brain
-Inability to communicate
-Thai Mental State Examination (TMSE) score less than 23

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
17-item Hamilton rating scale for depression Thai version (THAI HRS-D 17) 0, 2nd, 6th and 14th week Assessment form
Secondary Outcome Measures
NameTimeMethod
Modified Barthel Index 0, 2nd, 6th and 14th week Assessment form,Brunnstrom stages of stroke recovery 0, 2nd, 6th and 14th week Assessment form,Adverse effects All time Medical record, interview
© Copyright 2025. All Rights Reserved by MedPath